View PDF Version - RePub - Erasmus Universiteit Rotterdam

carcinomas. Genes Chrom Cancer 2:191-197.
LatifF, Tory K, Gnarra J, Yao M, Duh FM, Stackhouse T et al. (1993) Identification of the von Hippel-Lindau
disease tumor suppressor gene. Science 260: 1317-1320.
Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernslein A (1989) High incidence of lung, bone, and
lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Bioi 9: 3982-
3991.
Leach FS, Nicolaides NC, Papdopoulos N, Liu B, Jen J, Parsons R, Peltomaki P et al. (1993) Mutations of
a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215-1225.
Lee WH, Bookstein R, Hong F, Young U, Shew JY, Lee EYHP (1987) Human retinoblastoma susceptibility
gene: cloning, identification and sC{juence. Science 235: 1394-1399.
Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH (1988) Inactivation of the retinoblastoma
susceptibility gene in human breast cancers. Science 241:218-221.
Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene
in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet 3: 122-126.
Leister I, Weith A, Bruderlein S, Cziepluch C, Kanwanpong 0, Sclag P, Schwab M (1990) Human colorectal
cancer: high frequency of deletions at chromosome Ip35. Cancer Res 50:7232-7235.
Levine AJ, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453-456.
Levine N. (1992) The p53 tumor-suppressor gene. N Engl J Med 326:1350-1352.
Levinson G, Gutman GA (1987) High frequencies of short frameshins in poly-CAITG tandem repeats borne
by bacteriophage M13 in Escherichia coli K-12. Nucl Acids Res 15:5323-5338.
Li Y, Dollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K et al. (1992) Somatic mutations in the
neurofibromatosis I gene in human tumors. Cell 69:275-281.
Lindblom A, Tannergard P, Werelius D, Nordenskji)ltl M (1993) Genetic mapping of a sfXond locus
predisposing to hereditary non-polyposis colon cancer. Nature Genet 5:279-282.
Little MH, Williamson KA, Mannens M, Kelsey A, Gostlen C, Hastie ND, van Heyningen V (1993) Evidence
that WTl mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hu Mol Genel
2:259-264.
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TO. (1992): Altered cell cycle arrest and gene
amplification potential accompany loss of wild-type p53. Cell 70:923-935.
Lowe SW, Ruley HE, Jacks T, Housman DE (1993a) p53-Dependenl apoptosis modulates the cytotoxicity of
anticancer agents. Cell 74:957-967.
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (l993b) p53 is required for radiation induced
apoptosis in mouse thymocytes. Nature 362:847-849.
Ludlow JW, DeCaprio JA, Huang CM, Lee WH, Paucha E, Livingston DM (1989) SV40 large T antigen binds
preferentially to an underphosphorylated member of the retinohlastoma susceptihility gene product family. Cell
56:57-65.
Mack DH, Vartikar J, Pipas JM, Laimins LA (1993) Specific repression ofTATA-mediated but not initialormediated
transcription by wild-type p53, Nature 363:281-283.
Malkin D, Li FP, Strong LC , Fraumeni JF, Nelson CE, Kim DH, Kassel J et al. (1990) Germ line p53
mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238.
Maltby EL, Ironside JW, Batlersby RDE (1988) Cytogenetic studies in 50 meningiomas. Cancer Genet
Cytogenet 31: 199-210.
Martin GS (1970) ROllS sarcoma virus: a function required for the maintenance of the transformed stale. Nature
227: 1021-1023.
Marx J (1989) Many gene changes found in cancer. Science 246: 1386-1388.
Marx J (1993) New colon cancer gene discovered. Science 260:751-752.
47